National Peroxide Ltd is Rated Buy

Rating Overview and Context

On 04 May 2026, MarketsMOJO revised National Peroxide Ltd’s rating from 'Sell' to 'Buy', reflecting a significant improvement in the company’s overall profile. This change was accompanied by a substantial increase in the Mojo Score, which rose by 29 points from 43 to 72, signalling a more favourable investment stance. While the rating update marks a pivotal moment, it is essential to understand the stock’s current fundamentals and market behaviour as of 07 May 2026 to appreciate the rationale behind this recommendation.

Here’s How the Stock Looks Today

As of 07 May 2026, National Peroxide Ltd exhibits a robust set of financial and market indicators that underpin its Buy rating. The company operates within the Commodity Chemicals sector and is classified as a microcap, which often entails higher volatility but also potential for growth. The stock has demonstrated strong returns across multiple time frames, with a one-month gain of 71.74% and a year-to-date return of 36.75%. Over the past year, the stock has delivered an 11.89% return, reflecting steady appreciation despite broader market fluctuations.

Quality Assessment

The company’s quality grade is assessed as average, which indicates a stable operational foundation but with room for improvement in certain areas. Notably, National Peroxide Ltd is net-debt free, a significant strength that reduces financial risk and enhances balance sheet resilience. The firm has also reported very positive quarterly results, including a remarkable 333.33% growth in net profit as of March 2026. This growth is supported by the highest quarterly net sales of ₹85.68 crores and a PBDIT of ₹14.88 crores, with an operating profit margin of 17.37%, all of which highlight operational efficiency and effective cost management.

Valuation Perspective

Valuation is a key factor in the Buy rating, with the company receiving a very attractive valuation grade. The stock trades at a price-to-book value of 1, which is considered a discount relative to its peers’ historical averages. This valuation metric suggests that the stock is reasonably priced, offering investors an opportunity to acquire shares at a favourable cost relative to the company’s net asset value. Additionally, the company’s price-to-earnings growth (PEG) ratio stands at a low 0.1, indicating that earnings growth is not fully priced into the stock, which could imply further upside potential.

Financial Trend Analysis

The financial trend for National Peroxide Ltd is very positive, supported by consistent profit growth and improving operational metrics. The company has declared positive results for two consecutive quarters, signalling sustained momentum. Over the past year, profits have surged by an impressive 616.4%, a testament to the company’s ability to enhance profitability amid challenging market conditions. Return on equity (ROE) is currently at 3.2%, which, while modest, is complemented by the company’s strong earnings growth trajectory and net-debt free status.

Technical Outlook

From a technical standpoint, the stock is mildly bullish. Despite a slight decline of 1.29% on the most recent trading day, the stock’s performance over the past week (+40.24%) and three months (+50.84%) indicates strong upward momentum. This technical strength supports the Buy rating by suggesting that market sentiment remains positive and that the stock may continue to trend higher in the near term.

Investment Implications

For investors, the Buy rating on National Peroxide Ltd reflects a balanced view that combines attractive valuation, improving financial health, and positive technical signals. The company’s net-debt free position and significant profit growth reduce downside risks, while the valuation metrics suggest the stock is reasonably priced for further appreciation. The mild bullish technical trend adds confidence that the stock’s price momentum is sustainable. Investors seeking exposure to the Commodity Chemicals sector with a microcap profile may find National Peroxide Ltd a compelling addition to their portfolio, especially given its recent performance and growth prospects.

Shareholding and Market Position

Majority ownership by promoters provides a stable shareholder base, which often translates into aligned interests between management and investors. This factor adds to the confidence in the company’s strategic direction and governance. As a microcap stock in the Commodity Chemicals sector, National Peroxide Ltd operates in a niche market segment that can offer growth opportunities driven by industrial demand and chemical product innovation.

Summary of Key Metrics as of 07 May 2026

To summarise, the stock’s key performance indicators as of today include:

• Mojo Score: 72.0 (Buy grade)
• Net Profit growth: 333.33% in the latest quarter
• Net Sales (quarterly): ₹85.68 crores (highest recorded)
• PBDIT (quarterly): ₹14.88 crores (highest recorded)
• Operating Profit Margin: 17.37%
• Return on Equity (ROE): 3.2%
• Price to Book Value: 1 (very attractive valuation)
• PEG Ratio: 0.1 (indicating undervaluation relative to growth)
• Stock Returns: 1M +71.74%, YTD +36.75%, 1Y +11.89%

These figures collectively support the Buy rating and suggest that National Peroxide Ltd is positioned for continued growth and value creation.

Conclusion

National Peroxide Ltd’s current Buy rating by MarketsMOJO is grounded in a comprehensive evaluation of quality, valuation, financial trends, and technical factors. The company’s net-debt free status, strong profit growth, attractive valuation, and positive market momentum combine to present a compelling investment case. While the quality grade is average, the other parameters more than compensate, making this stock a noteworthy consideration for investors seeking exposure to the Commodity Chemicals sector with growth potential. As always, investors should consider their risk tolerance and investment horizon when evaluating microcap stocks.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today